Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (162) 162
humans (159) 159
hepatitis c virus (125) 125
hepatitis c (123) 123
male (99) 99
female (97) 97
hepatitis (95) 95
adult (87) 87
gastroenterology & hepatology (73) 73
health aspects (72) 72
hcv (68) 68
infectious diseases (68) 68
virus diseases (59) 59
antiviral agents - therapeutic use (56) 56
middle aged (54) 54
infection (53) 53
substance abuse, intravenous - complications (53) 53
hiv (52) 52
hepatitis c - drug therapy (51) 51
genotype (49) 49
interferon (49) 49
substance abuse (49) 49
hepatitis c - epidemiology (47) 47
analysis (45) 45
drug therapy (44) 44
epidemiology (44) 44
infections (44) 44
drugs (43) 43
drug use (42) 42
hepacivirus - genetics (42) 42
article (41) 41
care and treatment (38) 38
people (36) 36
drug abuse (35) 35
hepatitis c - virology (35) 35
medical research (35) 35
prevention (35) 35
virology (35) 35
people who inject drugs (33) 33
risk factors (33) 33
immunology (32) 32
treatment (32) 32
medicine, experimental (31) 31
users (31) 31
young adult (31) 31
australia (30) 30
prevalence (30) 30
treatment outcome (28) 28
virus-infection (28) 28
hcv infection (27) 27
human immunodeficiency virus--hiv (27) 27
prospective studies (26) 26
pwid (26) 26
ribavirin (26) 26
care (25) 25
cohort studies (25) 25
hepatitis c - complications (25) 25
viruses (25) 25
drug users (24) 24
hepatitis c - diagnosis (24) 24
hepatitis c, chronic - drug therapy (24) 24
inject drugs (24) 24
injections (24) 24
management (24) 24
microbiology (24) 24
public health (24) 24
sustained virological response (24) 24
liver diseases (22) 22
antiviral agents (21) 21
hepacivirus (21) 21
injection-drug users (21) 21
research (21) 21
internal medicine (20) 20
reinfection (20) 20
therapy (20) 20
biological response modifiers (19) 19
digestive system diseases (19) 19
gastroenterology and hepatology (19) 19
hepatitis c - prevention & control (19) 19
hepatitis c - transmission (19) 19
hepatitis-c virus (19) 19
incidence (19) 19
ribavirin - therapeutic use (19) 19
rna (19) 19
medical education (18) 18
recurrence (18) 18
antiviral treatment (17) 17
barriers (17) 17
interferon-alpha - therapeutic use (17) 17
methadone (17) 17
mortality (17) 17
plus ribavirin (17) 17
psychiatry (17) 17
viral load (17) 17
hiv infections - complications (16) 16
injecting drug use (16) 16
opioid substitution therapy (16) 16
substance abuse, intravenous - epidemiology (16) 16
treatment programs (16) 16
cohort (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Epidemiology and natural history of HCV infection
by Hajarizadeh, Behzad and Grebely, Jason and Dore, Gregory J
Nature Reviews Gastroenterology and Hepatology, ISSN 1759-5045, 09/2013, Volume 10, Issue 9, pp. 553 - 562
Worldwide, an estimated 130-170 million people have HCV infection. HCV prevalence is highest in Egypt at >10% of the general population and China has the most... 
UNITED-STATES | DRUG-USERS | HEPATOCELLULAR-CARCINOMA | RISK-FACTORS | HEPATITIS-C-VIRUS | MOLECULAR EPIDEMIOLOGY | LIVER FIBROSIS PROGRESSION | GASTROENTEROLOGY & HEPATOLOGY | CHANGING PATTERN | INTRAFAMILIAL TRANSMISSION | SPONTANEOUS CLEARANCE | Morbidity - trends | Global Health | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - epidemiology | DNA, Viral - genetics | Disease Progression | Causes of | Genetic aspects | Research | Hepatitis C | Epidemiology | Distribution
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
by Grebely, Jason, Dr and Prins, Maria, Prof and Hellard, Margaret, Prof and Cox, Andrea L, Prof and Osburn, William O, PhD and Lauer, Georg, MD and Page, Kimberly, PhD and Lloyd, Andrew R, Prof and Dore, Gregory J, Prof and Int Collaboration Incident HIV and International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3)
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 5, pp. 408 - 414
Summary Hepatitis C virus (HCV) was discovered more than two decades ago, but progress towards a vaccine has been slow. HCV infection will spontaneously clear... 
Infectious Disease | SPONTANEOUS VIRAL CLEARANCE | SPONTANEOUS HCV CLEARANCE | GENETIC-VARIATION | INFECTIOUS DISEASES | NEUTRALIZING ANTIBODIES | ACUTE-PHASE | SINGLE-SOURCE OUTBREAK | INFECTION | NATURAL-HISTORY | ADAPTIVE IMMUNE-RESPONSES | 2 DECADES | Viral Hepatitis Vaccines | Hepacivirus - immunology | Humans | Hepatitis C - virology | Hepacivirus - physiology | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Hepatitis C - etiology | Virus diseases | Medical research | Medicine, Experimental | Vaccines | Hepatitis C virus | Health aspects | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
by Bruggmann, Philip and Grebely, Jason
International Journal of Drug Policy, ISSN 0955-3959, 2015, Volume 26, Issue 1, pp. S22 - S26
Abstract People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many countries. HCV transmission continues among PWID,... 
Internal Medicine | Medical Education | Hepatitis C | PWID | SUBSTANCE ABUSE | Drug Costs | Needle-Exchange Programs - organization & administration | Prevalence | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Cost of Illness | Hepatitis C - economics | Health Services Accessibility | Antiviral Agents - adverse effects | Harm Reduction | Hepatitis C - epidemiology | Opiate Substitution Treatment - methods | Health Policy | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Virus diseases | Antiviral agents | Health care reform | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Disease prevention | Hepatitis | Antiretroviral drugs | Injections | Human immunodeficiency virus--HIV | Health care access | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Direct-Acting antiviral agents for HCV infection affecting people who inject drugs
by Grebely, Jason and Hajarizadeh, Behzad and Dore, Gregory J
Nature Reviews Gastroenterology and Hepatology, ISSN 1759-5045, 11/2017, Volume 14, Issue 11, pp. 641 - 651
Globally, 12 million people are estimated to have injected drugs in the past year, 50% of whom have chronic HCV infection, with people who have previously... 
SUSTAINED VIROLOGICAL RESPONSE | GENOTYPE 1-INFECTED PATIENTS | HEPATITIS-C VIRUS | SELECT COUNTRIES | HISTORICAL EPIDEMIOLOGY | DRIED BLOOD SPOT | POINT-OF-CARE | OPIOID SUBSTITUTION THERAPY | RANDOMIZED CONTROLLED-TRIAL | GASTROENTEROLOGY & HEPATOLOGY | VIRAL-HEPATITIS | Hepatitis C - psychology | Substance Abuse, Intravenous | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Humans | Drugs | Antiviral agents | Risk groups | Opioids | Clinical trials | Chronic infection | Infections | Interferon
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale‐up in the age of direct‐acting antivirals
by Martin, Natasha K and Vickerman, Peter and Grebely, Jason and Hellard, Margaret and Hutchinson, Sharon J and Lima, Viviane D and Foster, Graham R and Dillon, John F and Goldberg, David J and Dore, Gregory J and Hickman, Matthew
Hepatology, ISSN 0270-9139, 11/2013, Volume 58, Issue 5, pp. 1598 - 1609
Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as... 
OPIATE SUBSTITUTION THERAPY | COST-EFFECTIVENESS | RISK | METHADONE-MAINTENANCE | INFECTION | COHORT | GLOBAL EPIDEMIOLOGY | PREVALENCE | HUMAN-IMMUNODEFICIENCY-VIRUS | USERS | GASTROENTEROLOGY & HEPATOLOGY | Models, Theoretical | Prevalence | Antiviral Agents - therapeutic use | Hepatitis C - epidemiology | Humans | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Hepatitis | Hepatology | Human immunodeficiency virus--HIV | Viral Hepatitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis
by Esther J. Aspinall and Stephen Corson and Joseph S. Doyle and Jason Grebely and Sharon J. Hutchinson and Gregory J. Dore and David J. Goldberg and Margaret E. Hellard
Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 2, pp. S80 - S89
Background. Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain... 
Injections | Health outcomes | Chronic hepatitis | Infections | Reinfection | Hepatitis C | Hepacivirus | Genotypes | Disease risks | Virology | People who inject drugs | Treatment | treatment | INFECTIOUS DISEASES | hepatitis C | COMBINATION THERAPY | MICROBIOLOGY | RIBAVIRIN | MODEL | IMMUNOLOGY | ADHERENCE | CARE | SUSTAINED VIROLOGICAL RESPONSE | REINFECTION | people who inject drugs | USERS | Recurrence | Medication Adherence | Hepatitis C - drug therapy | Humans | Treatment Outcome | Substance Abuse, Intravenous - complications | Viral Load
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
by Jason Grebely and Megan Oser and Lynn E. Taylor and Gregory J. Dore
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 1, pp. S19 - S25
The majority of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection occurs among persons who inject drugs. Rapid improvements in... 
hepatitis C virus | human immunodeficiency virus | treatment | barriers | coinfection | drug users | INFECTIOUS DISEASES | MANAGEMENT | HIV COINFECTION | INCREASES | MICROBIOLOGY | IMMUNOLOGY | PHYSICIANS | CARE | INJECTION-DRUG USERS | THERAPY | ANTIVIRAL TREATMENT | INFECTION | OUTCOMES | HIV Infections - prevention & control | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Coinfection - prevention & control | Humans | Infection Control - methods | Hepatitis C - diagnosis | HIV Infections - diagnosis | HIV Infections - complications | Coinfection - diagnosis | HIV Infections - drug therapy | Hepatitis C - complications | Hepatitis C - prevention & control | Substance Abuse, Intravenous - complications | Hepatitis C Virus-HIV Co-Infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
by Peacock, Amy and Leung, Janni and Larney, Sarah and Colledge, Samantha and Hickman, Matthew and Rehm, Jürgen and Giovino, Gary A and West, Robert and Hall, Wayne and Griffiths, Paul and Ali, Robert and Gowing, Linda and Marsden, John and Ferrari, Alize J and Grebely, Jason and Farrell, Michael and Degenhardt, Louisa
Addiction, ISSN 0965-2140, 10/2018, Volume 113, Issue 10, pp. 1905 - 1926
Aims This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of... 
epidemiology | prevalence | cocaine | opioid | amphetamine | cannabis | mortality | Alcohol | tobacco | substance dependence | SYSTEMATIC ANALYSIS | COUNTRIES | PSYCHIATRY | INJURY | POPULATIONS | SMOKING PREVALENCE | SUBSTANCE ABUSE | DISEASE | INJECT DRUGS | PEOPLE | BURDEN | BEHAVIORS | Alcoholism | Mortality | Opioids | Illegal drugs | Marijuana | Drinking of alcoholic beverages | Statistics | Epidemiology | Central nervous system agents | Smoking | Drugs | Drug abuse | Identification methods | Income | Tobacco smoking | Alcohol use | Human populations | Cannabis | Dependence | Age | Drug use | Narcotics | Data acquisition | Disease control | Substance use | Tobacco | Amphetamine | Crime | Data collection | Amphetamines | Fatalities | Cocaine | Drug dependence
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
by Janjua, Naveed Z and Kuo, Margot and Yu, Amanda and Alvarez, Maria and Wong, Stanley and Wong, Jason and Cook, Darrel and Grebely, Jason and Butt, Zahid A and Samji, Hasina and Ramji, Alnoor and Tyndall, Mark and Krajden, Mel
EBioMedicine, ISSN 2352-3964, 10/2016, Volume 12, Issue C, pp. 189 - 195
Population-level monitoring of hepatitis C virus (HCV) infected people across the cascade of care identifies gaps in access and engagement in care and... 
Prevalence | Treatment | Engagement with care | Cascade of care | Linkage with care | Hepatitis C | Testing | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS-INFECTION | METAANALYSIS | TRENDS | CIRRHOSIS | DRUGS | PEOPLE | VALIDITY | Hepatitis C - therapy | Coinfection | Antiviral Agents - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Genotype | Male | Treatment Outcome | Molecular Typing | Hepatitis C - diagnosis | Delivery of Health Care | Hepatitis C - epidemiology | RNA, Viral | Hepatitis C - virology | Adult | Female | Aged | Population Surveillance | British Columbia - epidemiology | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
by Nolan, Seonaid and Dias Lima, Viviane and Fairbairn, Nadia and Kerr, Thomas and Montaner, Julio and Grebely, Jason and Wood, Evan
Addiction, ISSN 0965-2140, 12/2014, Volume 109, Issue 12, pp. 2053 - 2059
AimsTo determine the relationship between methadone maintenance therapy (MMT) and hepatitis C (HCV) seroconversion among illicit drug users. DesignA... 
Illicit drug use | Opioid | HCV | Methadone | Hepatitis C | Incident infection | Seroconversion | UNITED-STATES | incident infection | OPIATE SUBSTITUTION THERAPY | VIRUS-INFECTION | seroconversion | PSYCHIATRY | hepatitis C | opioid | PREVENTION | ANTIRETROVIRAL THERAPY | SUBSTANCE ABUSE | PREVALENCE | NATURAL-HISTORY | HIV | PROGRAMS | INJECT DRUGS | methadone | illicit drug use | Substance-Related Disorders - rehabilitation | Prospective Studies | Humans | Male | British Columbia | Alcoholism - epidemiology | Alcoholism - rehabilitation | Opioid-Related Disorders - epidemiology | Opioid-Related Disorders - rehabilitation | Street Drugs | Young Adult | Substance-Related Disorders - epidemiology | Hepatitis C - epidemiology | Adult | Female | Methadone - administration & dosage | Opiate Substitution Treatment | Cohort Studies | Biological products | Hepatitis C virus | Drug therapy | Analysis | Hepatitis | Drug abuse | Substance abuse treatment | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
by Grebely, Jason and Page, Kimberly and Sacks-Davis, Rachel and van der Loeff, Maarten Schim and Rice, Thomas M and Bruneau, Julie and Morris, Meghan D and Hajarizadeh, Behzad and Amin, Janaki and Cox, Anea L and Kim, Arthur Y and McGovern, Barbara H and Schinkel, Janke and George, Jacob and Shoukry, Naglaa H and Lauer, Georg M and Maher, Lisa and Lloyd, Anew R and Hellard, Margaret and Dore, Gregory J and Prins, Maria and Lauer, Georg and Morris, Meghan and Hahn, Judy and Rilla, Megan and Alavi, Maryam and Bouchard, Rachel and Evans, Jennifer and Grady, Bart and Aneja, Jasneet and Teutsch, Suzy and White, Bethany and Wells, Brittany and Zang, Geng and Applegate, Tanya and Matthews, Gail and Yeung, Barbara and Prince, Leslie Erin and Roy, Elise and Bates, Anna and Enriquez, Jarliene and Chow, Sammy and McCredie, Luke and Aitken, Campbell and Doyle, Joseph and Spelman, Tim and InC3 Study Grp and InC3 Study Group
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2014, Volume 59, Issue 1, pp. 109 - 120
Although 20%-40% of persons with acute hepatitis C virus (HCV) infection demonstrate spontaneous clearance, the time course and factors associated with... 
DRUG-USERS | COHORT | GASTROENTEROLOGY & HEPATOLOGY | SINGLE-SOURCE OUTBREAK | IMMUNE-RESPONSES | REINFECTION | Prospective Studies | Follow-Up Studies | Humans | Hepacivirus - genetics | Genotype | Hepatitis C - genetics | Male | Interleukins - genetics | Hepatitis C - epidemiology | Hepatitis C - virology | Sex Factors | Adult | Female | Remission, Spontaneous | Confidence intervals | Hepatitis | Genotype & phenotype | Females | Human immunodeficiency virus--HIV | Hepatology | hepatitis C virus | incident infection | HIV | injection drug use | longitudinal studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights